The pharmacological treatment of epilepsy: recent advances and future perspectives
Author:
Open Access
- 17 September 2021
- journal article
- review article
- Published by Springer Nature in Acta Epileptologica
- Vol. 3 (1) , 1-11
Abstract
The pharmacological armamentarium against epilepsy has expanded considerably over the last three decades, and currently includes over 30 different antiseizure medications. Despite this large armamentarium, about one third of people with epilepsy fail to achieve sustained seizure freedom with currently available medications. This sobering fact, however, is mitigated by evidence that clinical outcomes for many people with epilepsy have improved over the years. In particular, physicians now have unprecedented opportunities to tailor treatment choices to the characteristics of the individual, in order to maximize efficacy and tolerability. The present article discusses advances in the drug treatment of epilepsy in the last 5 years, focusing in particular on comparative effectiveness trials of second-generation drugs, the introduction of new pharmaceutical formulations for emergency use, and the results achieved with the newest medications. The article also includes a discussion of potential future developments, including those derived from advances in information technology, the development of novel precision treatments, the introduction of disease modifying agents, and the discovery of biomarkers to facilitate conduction of clinical trials as well as routine clinical management.Keywords
This publication has 76 references indexed in Scilit:
- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled studyThe Lancet, 2016
- Managing drug-resistant epilepsy: challenges and solutionsNeuropsychiatric Disease and Treatment, 2016
- Five‐year extended follow‐up status of 10 patients with Dravet syndrome treated with fenfluramineEpilepsia, 2016
- Challenges in the clinical development of new antiepileptic drugsPharmacological Research, 2016
- Epilepsy: new advancesThe Lancet, 2015
- Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugsEpileptic Disorders, 2014
- The pharmacological treatment of epilepsy in adultsThe Lancet Neurology, 2011
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007